New miRNAs to evaluate ovarian reserve in patients with breast cancer

被引：0
|
作者：
El Moghrabi, S. [1 ]
Decanter, C. [2 ]
Pigny, P. [3 ]
Haouzi, D. [1 ]
Hamamah, S. [4 ]
机构：
[1] CHU Montpellier, Hop St Eloi, Inst Med Regenerat & Biotherapies IRMB, Inserm,U1203, Montpellier, France
[2] Ctr Hosp Univ Lille, EA Gametogenese & Qual Gamete, CHRU Lille, Serv Assistance Med Procreat & Preservat Fertil,H, Lille, France
[3] CHRU Lille, Lab Biochim Hormonol HMNO, Ctr Biol Pathol, Inserm,UMR S 1172, Lille, France
[4] CHU Montpellier, ART PGD Dept, Hop Arnaud de Villeneuve, Serv Biol Reprod, Montpellier, France
来源：
HUMAN REPRODUCTION | 2018年 / 33卷
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
P-508
引用
下载
收藏
页码：374 / 374
页数：1
相关论文
共 50 条
  • [21] Reduction of ovarian reserve in young early breast cancer patients: First data of a prospective cohort trial
    Sanders, Lea
    Wenners, Antonia Sophie
    Koss, Juliane
    Schem, Christian
    Bauer, Maret
    Grambach, Jana
    Schaefer, Fritz Werner
    Schulz, Ulrike
    Jonat, Walter
    Schmutzler, Andreas Gerd
    Mundhenke, Christoph
    JOURNAL OF CLINICAL ONCOLOGY, 2012, 30 (15)
  • [22] DYSREGULATED CANCER-SPECIFIC MiRNAs IN THE CIRCULATION OF BREAST CANCER PATIENTS
    Healy, N. A.
    Heneghan, H. M.
    Lowery, A. J.
    Miller, N.
    Kerin, M. J.
    EJC SUPPLEMENTS, 2010, 8 (06): : 14 - 14
  • [23] Ovarian stimulation in patients with breast cancer
    Munoz, Elkin
    Gonzalez, Naira
    Munoz, Luis
    Aguilar, Jesus
    Garcia Velasco, Juan A.
    ECANCERMEDICALSCIENCE, 2015, 9
  • [24] Ovarian Masses in Patients With Breast Cancer
    Kang, Kyung A.
    Lee, Jonghyun
    Kim, Hyun-Soo
    Park, Sung Yoon
    JOURNAL OF COMPUTER ASSISTED TOMOGRAPHY, 2022, 46 (05) : 716 - 721
  • [25] Influence of breast cancer prognostic factors on ovarian reserve and response to ovarian stimulation in fertility preservation
    Grynberg, M.
    Zeghari, F.
    Sais, E.
    Benoit, A.
    Rakrouki, S.
    Peigne, M.
    Sonigo, C.
    HUMAN REPRODUCTION, 2023, 38
  • [26] Women with increased risk for hereditary breast and/or ovarian cancer do not have diminished ovarian reserve
    Sighinolfi, G.
    Imbrogno, M. G.
    Grandi, G.
    Toss, A.
    Barbieri, E.
    Razzaboni, E.
    La Marca, A.
    HUMAN REPRODUCTION, 2022, 37 : I518 - I519
  • [27] Comprehensive analysis on diagnostic value of circulating miRNAs for patients with ovarian cancer
    Wang, Huiqing
    Wang, Tingting
    Shi, Wenpei
    Liu, Yuan
    Chen, Lizhang
    Li, Zhanzhan
    ONCOTARGET, 2017, 8 (39) : 66620 - 66628
  • [28] Identification of Ovarian Cancer Metastatic miRNAs
    Vang, Souriya
    Wu, Hsin-Ta
    Fischer, Andrew
    Miller, Daniel H.
    MacLaughlan, Shannon
    Douglass, Elijah
    Steinhoff, Margaret
    Collins, Colin
    Smith, Peter J. S.
    Brard, Laurent
    Brodsky, Alexander S.
    PLOS ONE, 2013, 8 (03):
  • [29] Identification of differentially expressed miRNAs in plasma samples of ovarian cancer patients
    Penyige, A.
    Szilagyi, M.
    Soltesz, B.
    Marton, E.
    Lukacs, J.
    Poka, R.
    Nagy, B.
    EUROPEAN JOURNAL OF HUMAN GENETICS, 2019, 27 : 1591 - 1592
  • [30] Diagnostic Significance of Exosomal miRNAs in the Plasma of Breast Cancer Patients
    Kwong, A.
    Ng, E. K. O.
    Leung, C. P. H.
    Chan, V.
    Li, R.
    Wong, C. L. P.
    Ma, E. S. K.
    CANCER RESEARCH, 2011, 71
12345